Microplasmin Degrades Fibronectin and Laminin at Vitreoretinal Interface and Outer Retina during Enzymatic Vitrectomy

REFERENCES

• Akiba J, Arzabe CW, Trempe CL. Posterior vitreous detachment and neovascularization in diabetic retinopathy. Ophthalmology 1990;97:889–891.
   PubMed Web of Science ®Google Scholar
• Akiba J, Quiroz MA, Trempe CL. Role of posterior vitreous detachment in idiopathic macular holes. Ophthalmology 1990;97:1610–1613.
   PubMed Web of Science ®Google Scholar
• Avunduk AM, Cetinkaya K, Kapicioglu Z, et al. The effect of posterior vitreous detachment on the prognosis of branch retinal vein occlusion. Acta Ophthalmol Scand 1997;75:441–442.
   PubMedGoogle Scholar
• Han DP, Abrams GW, Aaberg TM. Surgical excision of the attached posterior hyaloid. Arch Ophthalmol 1998;106:998–1000.
   Google Scholar
• Vander JF, Kleiner R. A method for induction of posterior vitreous detachment during vitrectomy. Retina 1992;12:172–173.
   PubMedGoogle Scholar
• Sebag J. Age-related changes in human vitreous structure. Graefe’s Arch Clin Exp Ophthalmol 1987;225:89–93.
   PubMed Web of Science ®Google Scholar
• Trese MT. Enzymatic vitreous surgery. Semin Ophthalmol 2000;15:116–121.
   PubMedGoogle Scholar
• Trese MT. Enzymatic-assisted vitrectomy. Eye 2002;16:365–368.
   PubMed Web of Science ®Google Scholar
• Sebag J. Pharmacologic vitreolysis (Editorial). Retina 1998;18:1–3.
   PubMed Web of Science ®Google Scholar
• Bhisitkul RB. Anticipation for enzymatic vitreolysis (Editorial). Br J Ophthalmol 2001;85:1–3.
   PubMed Web of Science ®Google Scholar
• Moorhead LC, Redburn DA, Kirkpatrick DS, et al. Bacterial collagenase proposed adjunct to vitrectomy with membranectomy. Arch Ophthalmol 1980;98:1829–1839.
   PubMedGoogle Scholar
• Hikichi T, Kado M, Yoshida A. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit. Retina 2000;20:195–198.
   PubMed Web of Science ®Google Scholar
• Wang FH, Wang ZL, Sun XD, et al. Safety and efficacy of dispase and plasmin in pharmacologic vitreolysis. Invest Ophthalmol Vis Sci 2004;45:3286–3290.
   PubMed Web of Science ®Google Scholar
• Shi GY, Wu HL. Isolation and characterization of microplasminogen: A low molecular weight form of plasminogen. J Biol Chem 1988;263:17071–17075.
   PubMed Web of Science ®Google Scholar
• Sakuma T, Tanaka M, Mizota A, et al. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes. Invest Ophthalmol Vis Sci 2005;46:3295–3299.
   PubMed Web of Science ®Google Scholar
• Gandorfer A, Rohleder M, Sethi C, et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci 2004;45:641–647.
   PubMed Web of Science ®Google Scholar
• Pearlstein E, Gold LI, Garcia PA. Fibronectin: A review of its structure and biological activity. Mol Cell Biochem 1980;29:103–128.
   PubMed Web of Science ®Google Scholar
• Yamada KM, Olden K. Fibronectins-adhesive glycoproteins of cell surface and blood. Nature 1978;275:179–184.
   PubMed Web of Science ®Google Scholar
• Terranova VP, Rao CN, Kalebic T, et al. Laminin receptor on human breast carcinoma cells. Proc Natl Acad Sci 1983;80:444–448.
   PubMed Web of Science ®Google Scholar
• Yamakawa R, Shirakawa H, Yoshimura N, et al. Involvement of fibronectin in in vitro regeneration of retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 1988;226:11–14.
   Google Scholar
• Libby RT, Champliaud MF, Claudepierre T, et al. Laminin expression in adult and developing retinae: Evidence of two novel CNS laminins. J Neurosci 2000;20:6517–6528.
   PubMed Web of Science ®Google Scholar
• Nagai N, Demarsin E, Van HB, et al. Recombinant human microplasmin: Production and potential therapeutic properties. J Thro Haem 2003;1:307–313.
   PubMed Web of Science ®Google Scholar
• Chen W, Huang X, Ma XW, et al. Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activator. Eye 2008;22:300–307.
   PubMed Web of Science ®Google Scholar
• Hales AM, Chamberlain CG, Dreher B, et al. Intravitreal injection of TGFbeta induces cataract in rats. Invest Ophthalmol Vis Sci 1999;40:3231–3236.
   PubMed Web of Science ®Google Scholar
• Kamei M, Misono K, Lewis HA. Study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol 1999;128:739–746.
   PubMed Web of Science ®Google Scholar
• Mahmoud TH, Peng YW, Proia AD, et al. Recombinant tissue plasminogen activator injected into the vitreous cavity may penetrate the retinal veins of a porcine model of vascular occlusion. Brit J Ophthal 2006;90:911–915.
   PubMedGoogle Scholar
• Weizer JS, Fekrat S. Intravitreal tissue plasminogen activator for the treatment of central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2003;34:350–352.
   Google Scholar
• Burgeson RE, Chiquet M, Deutzmann R, et al. A new nomenclature for the laminins. Matrix Biol 1994;14:209–211.
   PubMed Web of Science ®Google Scholar
• Timpl R. Macromolecular organization of basement membranes. Curr Opin Cell Biol 1996;8:618–624.
   PubMed Web of Science ®Google Scholar
• Miner JH, Patton BL, Lentz SI, et al. The laminin alpha chains: Expression, developmental transitions, and chromosomal locations of a1–5, identification of heterotrimeric laminins 8–11, and cloning of a novel a3 isoform. J Cell Biol 1997;137:685–701.
   PubMed Web of Science ®Google Scholar
• Libby RT, Champliaud MF, Claudepierre T, et al. Laminin expression in adult and developing retinae: Evidence of two novel CNS laminins. J Neurosci 2000;20:6517–6528.
   PubMed Web of Science ®Google Scholar
• Sordat BC, Tran-Thang C. Laminin degradation by human colon carcinoma cells: A role for urinary and tissue plasminogen activators. Invasion Metastasis 1995;14:223–233.
   Google Scholar
• Goldfinger LE, Jiang LH, Hopkinson SB, et al. Spatial regulation and activity modulation of plasmin by high affinity binding to the G domain of the a3 subunit of laminin-5. J Bio Chem 2000; 275:34887–34893.
   PubMed Web of Science ®Google Scholar
• Indyk JA, Chen ZL, Tsirka SE, et al. Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury. Neuroscience 2003;116 359–371.
   PubMed Web of Science ®Google Scholar
• Romberger DJ. Fibronectin. Int J Biochem Cell Biol 1997;29:939–943.
   PubMed Web of Science ®Google Scholar
• Kohno T, Sorgente N, Ishibashi T, et al. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci 1987;28:506–514.
   PubMed Web of Science ®Google Scholar
• Terranova VP, Rohrbach BH, Martin GR. Role of laminin in the attachment of PAM cells to basement membrane collagen. Cell 1980;22:719–730.
   PubMed Web of Science ®Google Scholar
• Liotta LA, Goldfarb RH, Brundage R, et al. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 1981;41:4629–4636.
   PubMed Web of Science ®Google Scholar
• Men G, Peyman GA, Genaidy M, et al. The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment. Retina 2004;24:199–209.
   PubMed Web of Science ®Google Scholar